116,170 Shares in Perrigo Company plc $PRGO Bought by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. bought a new stake in Perrigo Company plc (NYSE:PRGO) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 116,170 shares of the company’s stock, valued at approximately $1,621,000.

A number of other institutional investors and hedge funds also recently modified their holdings of PRGO. KBC Group NV increased its position in shares of Perrigo by 61.3% during the first quarter. KBC Group NV now owns 6,283 shares of the company’s stock valued at $67,000 after acquiring an additional 2,388 shares during the last quarter. Parvin Asset Management LLC purchased a new position in Perrigo in the second quarter worth $79,000. Allworth Financial LP boosted its position in Perrigo by 489.1% in the second quarter. Allworth Financial LP now owns 9,390 shares of the company’s stock worth $98,000 after purchasing an additional 7,796 shares during the last quarter. Whitebox Advisors LLC purchased a new position in Perrigo in the first quarter worth $111,000. Finally, Integrated Wealth Concepts LLC bought a new position in Perrigo in the 2nd quarter valued at $126,000. 95.91% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on PRGO shares. Weiss Ratings raised Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th. Wall Street Zen cut Perrigo from a “strong-buy” rating to a “buy” rating in a research note on Sunday, September 27th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $19.33.

Perrigo Stock Performance

NYSE:PRGO opened at $15.95 on Thursday. The company has a market capitalization of $2.21 billion, a P/E ratio of -1.27, a P/E/G ratio of 1.85 and a beta of 0.69. The business has a fifty day simple moving average of $14.47 and a two-hundred day simple moving average of $12.20. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.32 and a quick ratio of 1.32. Perrigo Company plc has a 1 year low of $9.23 and a 1 year high of $22.02.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The business’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.06) EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, analysts expect that Perrigo Company plc will post 2.18 earnings per share for the current year.

Perrigo Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Friday, August 28th were paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 7.3%. The ex-dividend date was Friday, August 28th. Perrigo’s payout ratio is currently -9.27%.

Perrigo Profile

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.